CVS Health Beats Estimates, Raises Full-Year Outlook

Healthcare services operators should watch whether improved margins in government-funded benefits hold through the rest of 2026.

Updated on Nov. 4, 2026 in Healthcare

CVS Health Beats Estimates, Raises Full-Year Outlook

Live Poll

Do you think prescription drug costs are getting better or worse for you?

CVS Health reported third-quarter 2026 adjusted earnings of $2.09 per share on revenue of $108.4 billion, both ahead of Wall Street forecasts, and raised its full-year outlook. The results were released September 30, 2026, and the company's guidance changes affect investors and the healthcare services businesses that track its performance.

Why it matters

The beat was driven largely by better operating income in the Health Care Benefits segment, where the medical benefit ratio improved to 91.3% from 92.8% a year earlier, signaling progress in the company's margin recovery plan. Comparing the quarter with a prior year that carried a $5.7 billion goodwill impairment shows how much of the swing reflects that one-time charge rather than recurring operations.

Third-quarter GAAP diluted EPS was $1.68, compared with a loss of $3.13 per share a year earlier, which included the $5.7 billion goodwill impairment tied to the Health Care Delivery unit. The company also raised its cash flow from operations projection to at least $15.5 billion from at least $11.5 billion.

The players

CVS Health

CVS Health is a large integrated healthcare company combining a retail pharmacy network, a pharmacy benefit manager, and a health insurer, with a major Medicare and Medicaid presence.

The details

Adjusted operating income in the Health Care Benefits segment rose, and the segment's medical benefit ratio fell by 1.5 points on improved underlying performance in the government business, which is the mechanism behind the earnings beat. Operating income reached $3.6 billion, compared with an operating loss of $3.2 billion a year earlier, largely because the prior-year impairment did not recur and adjusted operating income grew 21.2%. Medical membership stood at 26.1 million at quarter end. The company also completed Rite Aid asset acquisitions in the third quarter of 2025 and deconsolidated Omnicare in September 2025, shifting the scope of its operating results.

September 2025: CVS deconsolidated Omnicare, LLC.
Third quarter of 2025: CVS completed the Rite Aid asset acquisitions.
2026: CVS exited its individual exchange business.
September 30, 2026: Third-quarter 2026 results were reported.

Market Landscape

The quarter's results reflect the company's margin recovery plan, which relies on better performance in its Health Care Benefits segment rather than on the one-time charges that dominated last year's figures. Comparing this period against the $5.7 billion goodwill impairment of the prior year shows how much of the year-over-year change is accounting-driven versus operational.

Operators in healthcare services and pharmacy benefit management should watch whether margin improvement in government-funded business continues, as it shapes reimbursement and pricing conversations. Companies that depend on the segment's partners should track the raised cash flow projection as a sign of financial stability in the sector.

The takeaway

The operating takeaway is that improved medical cost management, not just the absence of last year's impairment, is driving the earnings recovery. Businesses in the healthcare supply chain should compare their own cost trends against the 91.3% medical benefit ratio as a benchmark for the period.